Kvantify Unveils Qrunch: A Breakthrough in Quantum Computing for Chemistry and Biology

Kvantify, a pioneering Danish company in quantum computing software, announced the launch of its flagship product, Qrunch, on November 19, 2025, at the SC25 conference in St. Louis. Qrunch aims to be a game-changer for the chemical and biological industries by making quantum computing accessible to researchers without requiring extensive knowledge of quantum mechanics.

The Revolution of Chemical Simulations

Chemical simulations play a crucial role in innovation within the pharmaceutical and biotech sectors. They drive advancements that are vital for societal progress. Quantum computing emerges as a leading candidate to accelerate these innovative processes. However, three significant barriers have historically hindered its integration into businesses: limited accessibility for non-quantum specialists, inadequate scalability for real-world problem sizes, and a poor cost-benefit ratio.

Qrunch addresses these challenges by offering enterprise-level quantum technology tailored for chemical computations. It simplifies complex quantum operations into an intuitive interface, allowing scientists to develop and deploy quantum algorithms without extensive quantum expertise. This approach dramatically shortens development times compared to direct programming on quantum hardware, enabling chemists to focus on solving scientific problems rather than grappling with quantum gate sequences and qubit topology constraints.

A Unique Approach to Quantum Computing

Nikolaj Zinner, the Chief Strategy Officer at Kvantify, underscores one of Qrunch's critical differentiators—the domain-specific approach to quantum computing. This innovative strategy facilitates full utilization of quantum hardware capabilities. While conventional quantum software typically accesses only 10-30% of available qubits, Qrunch's chemistry-specific methods enable efficient execution across complete processor architectures. Validation has been achieved through molecular simulations involving up to 80 qubits on contemporary quantum processors, showcasing a three- to four-time enhancement in problem-solving capacity over standard methodologies.

For pharmaceutical and materials science applications, such capabilities translate into reduced project timelines, an expanded array of acceptable molecular systems, and the capacity to model larger, commercially relevant molecules. Lars Olsen, Senior Department Manager at Novonesis, articulated the impact of these innovations: "By using this type of calculation and subsequent analysis of enzyme behavior during catalysis, we can gain deeper insights into fundamental biological processes, potentially enhancing the efficiency of our existing enzyme products."

Extending the Boundaries of Computational Chemistry

Qrunch positions quantum computing as a transformative technology, extending the boundaries of solvable problems in computer chemistry. This promise is reinforced by Qrunch's compatibility across all major gate-based quantum computers, including those accessible via Amazon Braket, Amazon Web Services’ quantum computing service.

Additionally, Qrunch is closely integrated with the European quantum ecosystem, being launched in collaboration with IQM Quantum Computers, a leading company in superconducting quantum technology based in Europe. Jan Goetz, Co-CEO and Co-founder of IQM Quantum Computers, stated, "Powerful quantum software is a critical component in the commercialization of quantum computers. Kvantify Qrunch delivers precisely that. We are excited to work with Kvantify to strengthen the European quantum ecosystem and leverage synergies between hardware and software."

Qrunch is now available for researchers eager to explore the vast potential of quantum computing in their work. For more information, visit Kvantify's website. Kvantify is committed to revolutionizing molecular research by bridging quantum and classical computing methodologies, paving the way for unprecedented innovations in science and industry.